Inventor · disambiguated record
Michael P. Bevilacqua
Also filed as: BEVILACQUA MICHAEL · BEVILACQUA MICHAEL P
22 granted patents·24 pending applications·1,264 citations·filing 1988–2024
97Inventor score
Files withAMICROBE INC7BEVILACQUA MICHAEL6SOURCE PRECISION MEDICINE INC6UNIV CALIFORNIA5BRIGHAM & WOMENS HOSPITAL4
Top patents by PatentIndex Score
46 records- 0198US6096728AComposition and method for treating inflammatory diseasesAMGEN INC·Filed 1997·Granted Aug 1, 2000·322 cites·20 claims
- 0297US6964850B2Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesSOURCE PRECISION MEDICINE INC·Filed 2002·Granted Nov 15, 2005·142 cites·42 claims
- 0397US6692916B2Systems and methods for characterizing a biological condition or agent using precision gene expression profilesSOURCE PRECISION MEDICINE INC·Filed 2001·Granted Feb 17, 2004·164 cites·17 claims
- 0496US6733753B2Composition and method for treating inflammatory diseasesAMGEN INC·Filed 2001·Granted May 11, 2004·73 cites·16 claims
- 0594US6294170B1Composition and method for treating inflammatory diseasesAMGEN INC·Filed 1998·Granted Sep 25, 2001·122 cites·15 claims
- 0693US9446090B2Compositions and uses of antimicrobial materials with tissue-compatible propertiesAMICROBE INC·Filed 2013·Granted Sep 20, 2016·13 cites·18 claims
- 0793US6960439B2Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesSOURCE PRECISION MEDICINE INC·Filed 2002·Granted Nov 1, 2005·65 cites·27 claims
- 0891US5081034ACloned genes which encode elam-1BRIGHAM & WOMENS HOSPITAL·Filed 1988·Granted Jan 14, 1992·105 cites·3 claims
- 0988US9017730B2Compositions and uses of materials with high antimicrobial activity and low toxicityUNIV CALIFORNIA·Filed 2013·Granted Apr 28, 2015·13 cites·20 claims
- 1086US11298401B2Compositions and uses of antimicrobial materials with tissue-compatible propertiesAMICROBE INC·Filed 2016·Granted Apr 12, 2022·2 cites·17 claims
- 1186US11285189B2Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safetyAMICROBE INC·Filed 2018·Granted Mar 29, 2022·4 cites·33 claims
- 1286US5527785ASelectin receptor modulating compositionsUNIV CALIFORNIA·Filed 1993·Granted Jun 18, 1996·81 cites·7 claims
- 1385US2025121027A1Compositions and uses of antimicrobial materials with tissue-compatible propertiesAMICROBE INC·Filed 2024·Application pending·0 cites
- 1484US10448634B2Composition with high antimicrobial activity and low toxicityUNIV CALIFORNIA·Filed 2015·Granted Oct 22, 2019·5 cites·16 claims
- 1584US5403713AAntibodies specific for ELAM-1 and the use thereofBRIGHAM & WOMENS HOSPITAL·Filed 1993·Granted Apr 4, 1995·56 cites·1 claims
- 1683US7957909B2Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesSOURCE PRECISION MEDICINE INC·Filed 2005·Granted Jun 7, 2011·8 cites·4 claims
- 1781US5827837APolyanion anti-inflammatory agentsUNIV CALIFORNIA·Filed 1994·Granted Oct 27, 1998·75 cites·10 claims
- 1879US12016898B2Compositions and uses of antimicrobial materials with tissue-compatible propertiesAMICROBE INC·Filed 2022·Granted Jun 25, 2024·0 cites·4 claims
- 1976US8055452B2Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesLIFE TECHNOLOGIES CORP·Filed 2009·Granted Nov 8, 2011·3 cites·3 claims
- 2075US2020288709A1Composition with high antimicrobial activity and low toxicityUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 2173US12268722B2Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safetyAMICROBE INC·Filed 2022·Granted Apr 8, 2025·0 cites·17 claims
- 2267US8718946B2Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesBEVILACQUA MICHAEL·Filed 2011·Granted May 6, 2014·1 cites·12 claims
- 2365US2018060481A1Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profilesLIFE TECHNOLOGIES CORP·Filed 2017·Application pending·0 cites
- 2459US2015294064A1Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profilesLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 2559US2011288781A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesBEVILACQUA MICHAEL P·Filed 2011·Application pending·0 cites
- 2659US2012277998A1System And Methods For Characterizing A Biological Condition Or Agent Using Selected Gene Expression ProfilesBEVILACQUA MICHAEL P·Filed 2011·Application pending·0 cites
- 2756US2012041687A1Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profilesBEVILACQUA MICHAEL P·Filed 2011·Application pending·0 cites
- 2854US2008227655A1Assessment of effect of an agent on a human biological condition using rodent gene expression panelsBEVILACQUA MICHAEL·Filed 2007·Application pending·0 cites
- 2953US2004225445A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 3053US2004219568A1Systems and methods for characterizing a biological conditions or agent using selected gene expression profilesFiled 2003·Application pending·0 cites
- 3153US2004224322A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2003·Application pending·0 cites
- 3253US2004224333A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 3353US2023149333A1Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infectionsAMICROBE INC·Filed 2021·Application pending·0 cites
- 3453US2004225447A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 3553US2004225448A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 3653US2004225446A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 3753US2005287576A1Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profilesSOURCE PRECISION MEDICINE INC·Filed 2005·Application pending·0 cites
- 3852US2005060101A1Systems and methods for characterizing a biological condition or agent using precision gene expression profilesFiled 2003·Application pending·0 cites
- 3950US2011092390A1Assessment of effect of an agent on a human biological condition using rodent gene expression panelsSOURCE PRECISION MEDICINE INC·Filed 2010·Application pending·0 cites
- 4049US2008070243A1Gene expression profiling for identification, monitoring and treatment of multiple sclerosisBEVILACQUA MICHAEL·Filed 2006·Application pending·0 cites
- 4148US2011300542A1Gene Expression Profiling For Identification, Monitoring And Treatment Of Multiple SclerosisBEVILACQUA MICHAEL·Filed 2011·Application pending·0 cites
- 4246US2004225449A1Systems and methods for characterizing a biological condition or agent using selected gene expression profilesFiled 2004·Application pending·0 cites
- 4344US6166179AInducible endothelial surface protein mediating melanoma cell adhesion, antibodies, and usesBRIGHAM & WOMENS HOSPITAL·Filed 1993·Granted Dec 26, 2000·7 cites·4 claims
- 4439US2006115826A1Gene expression profiling for identification monitoring and treatment of multiple sclerosisBEVILACQUA MICHAEL·Filed 2005·Application pending·0 cites
- 4535US5821340AInducible endothelial surface protein mediating lymphoid and tumor cell adhesion: antibodies and usesBRIGHAM & WOMENS HOSPITAL·Filed 1989·Granted Oct 13, 1998·3 cites·4 claims
- 4635US2008183395A1Gene expression profiling for identification, monitoring and treatment of multiple sclerosisBEVILACQUA MICHAEL·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael P. Bevilacqua files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →